Precision oncology seeks to leverage molecular information about cancer to improve patient
outcomes. Tissue biopsy samples are widely used to characterize tumours but are limited by …

Introduction: Cancer is often diagnosed at late stages when the chance of cure is relatively
low and although research initiatives in oncology discover many potential cancer …

Metabolomics is the qualitative and quantitative assessment of the metabolites (small
molecules< 1.5 kDa) in body fluids. The metabolites are the downstream of the genetic …

Early detection and diagnosis of cancer can allow timely medical intervention, which greatly
improves chances of survival and enhances quality of life. Biomarkers play an important role …

Alzheimer's disease (AD) is the most common form of neurodegenerative dementia and
there is no cure to date. Biomarkers in cerebrospinal fluid (CSF) are already included in the …

Accurate, reliable, and objective biomarkers for Alzheimer's disease (AD), Parkinson's
disease (PD), and related age‐associated neurodegenerative disorders are urgently …

Background Alterations in protein glycosylation patterns have potentially been targeted for
biomarker discovery in a wide range of diseases including cancer. Although there have …

Mass spectrometry (MS) is an essential analytical technology on which the emerging omics
domains; such as genomics; transcriptomics; proteomics and metabolomics; are based. This …

Detailed knowledge of protein changes in cerebrospinal fluid (CSF) across healthy and
diseased individuals would provide a better understanding of the onset and progression of …

Ovarian cancer is one the common cancers that in women such pathological disease within
an organ might lead to noticeable changes in the proteomic patterns in serum. Mass …